Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $122.2300 (10.02%) ($122.2300 - $122.2500) on Thu. Jan. 14, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.25% (three month average) | RSI | 66 | Latest Price | $122.2300(10.02%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 2.8% a day on average for past five trading days. | Weekly Trend | LGND advances 4.6% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(56%) IWO(54%) IWM(51%) IWC(50%) XBI(50%) | Factors Impacting LGND price | LGND will decline at least -1.625% in a week (0% probabilities). VIXM(-23%) UUP(-17%) VXX(-15%) UNG(-3%) USO(-0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.625% (StdDev 3.25%) | Hourly BBV | 2.2 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $111.89(9.24%) | 10 Day Moving Average | $107.3(13.91%) | 20 Day Moving Average | $104.52(16.94%) | To recent high | 0% | To recent low | 52.1% | Market Cap | $1.964b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |